跳至主要内容
临床试验/NCT01687010
NCT01687010Unknown不适用

Diagnostic and Prognostic Value of Combination Biomarkers in the Critically Ill Patient With Sepsis.

Jianfeng Xie1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
300
试验地点
1

研究概览

简要总结

Sepsis is a common cause for morbidity and mortality in critically ill patients. With the development of medical skills, the mortality is still remain very high. Inappropriateness of initial antibiotic treatment is an important risk factor for mortality and effective antimicrobial administration within the first hour of documented hypotension was associated with increased survival to hospital discharge in adult patients with septic shock. However, the early treatment based on early diagnosis.But it is very difficult to diagnosis because of lack of specific clinic symptom and sign.When severe sepsis occur, biomarker could be helpful to diagnosis. Unfortunately, the diagnostic value of single biomarker is limited. Therefore, combine several biomarkers could enhance the diagnostic value.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Critically ill patients admitted into ICU

排除标准

  • Age younger than 18 years
  • Refuse to participate in this study

研究者

发起方
Jianfeng Xie
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jianfeng Xie

Physician of critical care department

Southeast University, China

研究点 (1)

Loading locations...

相似试验

Diagnostic and Prognostic Value of Combination... | 临床试验